Watch Ticker

Taysha Gene Therapies, Inc. Common Stock

Go to Taysha Gene Therapies, Inc. Common Stock Website

$2.74

0.00 (0.00%)

Live

Previous Close

$2.74

Day Range

$0 - $0

Previous Day Range

$2.65 - $2.775

Market Cap

$708.7 million USD

Day Vol.

Previous Day Vol.

2.8 million

Currency

USD

Primary Exchange

Nasdaq

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Hayleigh Collins - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies granted a new employee an option to purchase 90,000 shares of common stock under their 2023 Inducement Plan, with an exercise price of $2.63 and a 10-year term vesting over four years.

Related tickers: TSHA.

Read Full Article

N/A - Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

Taysha Gene Therapies announced details for three oral presentations at the 2025 IRSF Rett Syndrome Scientific Meeting, covering updates on its TSHA-102 clinical program for Rett syndrome and a symposium on natural history data.

Related tickers: TSHA.

Read Full Article

Trending Tickers

Please sign in to view